References
- Burgess DJ, Duffy E, Etzler F, Hickey A. Particle size analysis: AAPS workshop report, cosponsored by the food and drug administration, and United States Pharmacopeia. AAPS J 2004;6:1–12.
- Iacocca R, Burcham C and Hilden L. Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development. J Pharm Sci 2010;99:51–75.
- Rohrs BR, Amidon GE, Meury RH, Secreast PJ, King HM, Skoug CJ. Particle size limits to meet USP content uniformity criteria for tablets and capsules. J Pharm Sci 2006;95:1049–1059.
- Zhang Y, Johnson K. Effect of drug particle size on content uniformity of low-dose solid dosage forms. Int J Pharm 1997;154: 179–183.
- Huang CY, Sherry Ku M. Prediction of drug particle size and content uniformity in low-dose solid dosage forms. Int J Pharm 2010;383:70–80.
- Huang CY, Ku MS. Asymmetry effect of particle size distribution on content uniformity and over-potency risk in low-dose solid drugs. J Pharm Sci 2010;99:4351–4362.
- Shah N, Ahmed H. Content uniformity of a low dose pharmaceutical product. Particulat Sci Technol 1997;15:151–155.
- Ahmed H, Shah N. Formulation of low dose medicines-theory and practice. American Pharmaceut Rev 2006;3:1–5.
- Martinez L, Tchoreloff B, Madelaine B, Couarraze G. Active layering and direct compression of sugar spheres: content homogeneity in low-dose tablets. Pharm Technology Europe 2001(October); p. 1–5.
- McGinity JW, Chi-Tze Ku, Bodmeier R, Harris MR. Dissolution and uniformity properties of ordered mixes of micronized griseofulvin and a directly compressible excipient. Drug Dev Ind Pharm 1985;11:891–900.
- Hausman DS. Comparison of low shear, high shear, and fluid bed granulation during low dose tablet process development. Drug Dev Ind Pharm 2004;30:259–266.
- Wade A, Weller PJ eds Handbook of pharmaceutical excipients. Second Edition, Povidone: The Pharmaceutical Press. p 392–399, 1994.
- Albert A, Serjeant E. Determination of ionization constants by spectrophometry, Chapter 4 in “The Determination of Ionization Constants: A Laboratory Manual”. 3rd edition ed 1984 NY: Chapman and Hall.
- Desai D, Kothari S, Huang M. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. Int J Pharm 2008;354:77–81.
- Garekani H, Sadeghi F, Ghazi A. Increasing the aqueous solubility of acetaminophen in the presence of polyvinylpyrrolidone and investigation of the mechanisms involved. Drug Dev Ind Pharm 2003;29:173–179.
- Wen H, Morris KR, Park K. Study on the interactions between polyvinylpyrrolidone (PVP) and acetaminophen crystals: partial dissolution pattern change. J Pharm Sci 2005;94:2166–2174.
- Cho M, Mitchell A, Pernarowski M. Interaction of bishydroxycoumarin with polyvinylpyrrolidone. J Pharm Sci 1971;60:720–724.
- Tros de llarduya MC, Martin C, Goni MM, Martinez-Oharriz MC. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in solid state and in aqueous solution. Drug Dev Ind Pharm 1998;24:295–300.
- Desai D, Rao V, Guo H, Li D, Bolgar M. Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions. Int J Pharm 2007;342:87–94.
- Kenley RA, Jackson SE, Winterle JS, Shunko Y, Visor GC. Water soluble complexes of the antiviral drugs, 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine and acyclovir: the role of hydrophobicity in complex formation. J Pharm Sci 1986;75:648–653.